IRIS
PALLADINO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 156
NA - Nord America 45
AS - Asia 16
AF - Africa 4
OC - Oceania 1
Totale 222
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 72
US - Stati Uniti d'America 44
AT - Austria 29
FR - Francia 24
SE - Svezia 14
CN - Cina 9
BE - Belgio 6
DE - Germania 4
BG - Bulgaria 2
EG - Egitto 2
FI - Finlandia 2
IE - Irlanda 2
JP - Giappone 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
AU - Australia 1
CA - Canada 1
HK - Hong Kong 1
IN - India 1
UA - Ucraina 1
VN - Vietnam 1
Totale 222
Salva come PNG Salva come JPEG
Città #
Vienna 29
Strasbourg 20
Urbino 17
Chandler 12
Sundbyberg 11
Turin 9
Ashburn 7
Iesi 6
New York 6
Rome 5
Beijing 4
Cagliari 4
Louvain-la-Neuve 4
Nanjing 3
Ancona 2
Brussels 2
Cairo 2
Des Moines 2
Dublin 2
Helsinki 2
Kenitra 2
Los Angeles 2
Macao 2
Montegiorgio 2
Mugnano di Napoli 2
Palazzolo sull'Oglio 2
Taranto 2
Ulm 2
Villenave-d'Ornon 2
West Jordan 2
Évry 2
Bremen 1
Cascina 1
Enterprise 1
Fairfield 1
Falls Church 1
Ho Chi Minh City 1
Laurel 1
Melbourne 1
Mumbai 1
Princeton 1
St Louis 1
Tokyo 1
Toronto 1
Totale 184
Salva come PNG Salva come JPEG
Nome #
THE EXPRESSION OF THE KRAS mRNA ISOFORMS 4A AND 4B IN PLASMA: A COMPARISON BETWEEN LUNG ADENOCARCINOMA PATIENTS AND HEALTHY DONORS THROUGH LIQUID BIOPSY 127
KRAS4A, KRAS4B and PD-L1 circulating mRNA analysis and association with progression free survival in a population of metastatic NSCLC patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab by Liquid Biopsy 41
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab 26
Expression of circulating KRAS-4a and KRAS-4b mRNA isoforms in Patients with metastatic lung adenocarcinoma treated with Pembrolizumab or chemotherapy plus Pembrolizumab by liquid biopsy. Clinical impact and assoociation with circulating Pd-L1 18
2206P Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1 16
Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1 2
Totale 230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 872
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 0 0 0 0 0 0 0 0 30 8
2022/202355 3 9 4 4 5 11 3 2 4 3 1 6
2023/2024137 4 3 7 4 21 48 19 12 0 19 0 0
Totale 230